Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.50    0.50 (0.78%)
Bid:
64.70
Ask:
64.90
Spread: 0.20 (0.309%)
Market Cap: £569.81m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Tuesday broker round-up UPDATE

Tue, 27th Nov 2012 07:19
Aberdeen Asset Management: Citigroup raises target price from 320p to 345p and downgrades to neutral. JP Morgan raises target price from 330p to 414p, overweight rating unchanged. Credit Suisse moves target price from 323p to 380p, outperform rating kept. Exane BNP Paribas raises target price from 350p to 370p, outperform rating maintained.Aveva: Seymour Pierce initiates with a target price of 1780p and a sell recommendation.Big Yellow Group: Espirito Santo raises target price from 308p to 322p, natural rating maintained.Bovis Homes Group: UBS raises target price from 465p to 500p, neutral rating reiterated.Britvic: Canaccord Genuity downgrades to hold, target price of 410p kept. Numis upgrades to add, maintaining a target price of 451p.Capita Group: Shore Capital upgrades to hold.Carrs Milling: Investec raises target price from 1000p to 1125p, buy rating kept.Chemring: Investec reduces target price from 500p to 280p, buy recommendation maintained.Compass Group: Goldman Sachs cuts target price from 830p to 825p, buy rating reiterated.First Group: Nomura reduces target price from 330p to 204p and upgrades from reduce to neutral.Go Ahead Group: Nomura raises target price from 1480p to 1513p and upgrades from neutral to buy.Greencore: Investec raises target price from 90p to 100p, buy recommendation maintained.Halma: UBS moves target price from 375p to 385p, sell recommendation unchanged.Hochschild Mining: Goldman Sachs reduces target price from 420p to 400p, sell recommendation kept.IMI: Investec raises target price from 1100p to 1140p, buy rating remains unchanged.Informa: Morgan Stanley raises target price from 415p to 485p and upgrades to overweight.IP Group: Numis upgrades to add, target price of 126p remains unchanged.Johnson Matthey: Goldman Sachs reduces target price from 2850p to 2700p, buy recommendation maintained.Kryso Resources: Investec cuts target price from 42p to 41p, buy recommendation reiterated.Lloyds Banking Group: Barclays raises target price from 27p to 35p, underweight rating kept.National Express: Nomura reduces target price from 285p to 189p and downgrades from buy to neutral.Optos: Investec moves target price from 202p to 157p and downgrades from hold to sell.Renew Holdings: Numis initiates with a target price of 110p and a buy recommendation. WH Ireland raises target price from 125p to 130p, buy recommendation kept.Royal Bank of Scotland: Barclays raises target price from 270p to 330p, overweight rating unchanged. UBS raises target price from 287p to 328p and upgrades to buy.SAB Miller: UBS moves target price from 2850p to 2950p, neutral rating reiterated.Sanderson Group: WH Ireland moves target price from 55p to 57p, buy rating remains unchanged.Scapa Group: Numis upgrades to buy, maintaing a target price of 77p.SDL: Panmure Gordon downgrades from buy to hold, reiterating a target price of 538p.Servern Trent: Barclays reduces target price from 1695p to 1640p, equal weight rating remains unchanged.Shanks Group: Goldman Sachs moves target price from 118p to 119p, buy recommendation remains unchanged.Stagecoach: Nomura moves target price from 305p to 310p, buy recommendation maintained.Talk Talk Telecom: UBS raises target price from 200p to 240p, buy rating kept.Telecity: Berenberg reduces target price from 1100p to 990p, buy recommendation remains unchanged.TUI Travel: Barclays raises target price from 250p to 320p, overweight rating reiterated.Whitbread: Numis raises target price from 2350p to 2650p and upgrades to add.Zambeef: Panmure Gordon moves target price from 45p to 53p, buy rating kept.

Related News

LONDON MARKET CLOSE: FTSE 100 falls as OpenAI delay report knocks tech
3 days ago

LONDON MARKET CLOSE: FTSE 100 falls as OpenAI delay report knocks tech

(Alliance News) - The FTSE 100 ended lower on Friday while technology stocks fell as the New York Times reported OpenAI may delay its initial public o...

IN BRIEF: Chemring chair buys almost GBP200,000 in shares
3 days ago

IN BRIEF: Chemring chair buys almost GBP200,000 in shares

Chemring Group PLC - Hampshire, England-based provider of technology products and services to the aerospace, defence and security markets - Chair Tony...

Ip Group News

IN BRIEF: Prudential chair-designate Flint to join insurer on March 4
13 Feb 2026

IN BRIEF: Prudential chair-designate Flint to join insurer on March 4

Prudential PLC - London-based insurer - Confirms Douglas Flint's appointment as a non-executive director and chair-designate will become effective on ...

IP Group portfolio firm Microbiotica reports positive trial results
11 Feb 2026

IP Group portfolio firm Microbiotica reports positive trial results

(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trai...

Prudential names former HSBC veteran Flint as next chair
14 Jan 2026

Prudential names former HSBC veteran Flint as next chair

(Alliance News) - Prudential PLC on Wednesday said it has named Douglas Flint as its next chair, replacing Shriti Vadera, who will round off a roughly...

IN BRIEF: IP Group notes investee Pulmocide terminating phase 3 study
7 Jan 2026

IN BRIEF: IP Group notes investee Pulmocide terminating phase 3 study

IP Group PLC - London-based intellectual property commercialisation firm - Notes that portfolio company Pulmocide announced the termination of the Ope...

IP Group tumbles as portfolio company Pulmocide ends study for lead product
7 Jan 2026

IP Group tumbles as portfolio company Pulmocide ends study for lead product

(Sharecast News) - IP Group slumped on Wednesday after it said portfolio company Pulmocide has decided to end the Phase 3 study of its opelconazole pr...

IN BRIEF: IP Group completes GBP75 million share buyback
20 Nov 2025

IN BRIEF: IP Group completes GBP75 million share buyback

IP Group PLC - London-based intellectual property commercialisation firm - Completes GBP20 million extension of GBP75 million share buyback programme ...

IP Group notes potential income from Metsera obesity drugs
13 Oct 2025

IP Group notes potential income from Metsera obesity drugs

(Alliance News) - IP Group PLC on Monday reported "potential royalty income" from possible obesity drugs by Metsera Inc.

LONDON MARKET OPEN: Stocks up as Trump says US wants to "help" China
13 Oct 2025

LONDON MARKET OPEN: Stocks up as Trump says US wants to "help" China

(Alliance News) - European equities opened higher on Monday, as US-China trade tensions eased following the latest remarks from Donald Trump, just day...